NFE2L2 and neoplasm: In COVID-19: the inactivated NRF2 pathways downregulate HO-1 pathway, increase ACE2R expression and decrease anti-oxidase expression.In lung cancer: promotes aggressive proliferation, metastasis of tumors, and tumor resistance to oxidative stress, chemo- and radiotherapy.